(NVMI) Nova - Ratings and Ratios

Exchange: NASDAQ • Country: Israel • Currency: USD • Type: Common Stock • ISIN: IL0010845571

NVMI: Metrology, Systems, Instruments, Software, Hardware, Sensors

Nova Ltd. (NASDAQ:NVMI) is a leading provider of process control systems for the semiconductor manufacturing industry. Headquartered in Rehovot, Israel, the company operates globally, with a presence in key semiconductor hubs such as Taiwan, the United States, China, and Korea. Novas expertise lies in designing, developing, and selling metrology platforms that enable precise measurements of dimensional, films, materials, and chemical properties during various stages of semiconductor production. These measurements are critical for process control in steps like lithography, etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging.

The company serves a diverse range of customers within the integrated circuit manufacturing ecosystem, including logic manufacturers, foundries, memory producers, and process equipment suppliers. This broad customer base underscores Novas versatility and the critical role its solutions play in ensuring the quality and efficiency of semiconductor manufacturing processes. Nova Ltd., formerly known as Nova Measuring Instruments Ltd., rebranded in July 2021 to reflect its expanded scope and capabilities. Founded in 1993, the company has established itself as a trusted partner in the semiconductor industry, leveraging its deep technical expertise to deliver innovative metrology solutions.

From a financial perspective, Nova Ltd. has a market capitalization of approximately $7.8 billion, reflecting its significant presence in the industry. The companys trailing P/E ratio of 50.28 and forward P/E of 28.33 indicate investor confidence in its growth prospects. With a price-to-book ratio of 7.86 and a price-to-sales ratio of 12.77, Novas valuation metrics highlight its strong revenue generation and profitability. These figures are particularly relevant for investors and fund managers assessing the companys financial health and potential for future returns. For more information, visit their website at https://www.novami.com.

Additional Sources for NVMI Stock

NVMI Stock Overview

Market Cap in USD 5,264m
Sector Technology
Industry Semiconductor Equipment & Materials
GiC Sub-Industry Semiconductor Materials & Equipment
IPO / Inception 2000-04-07

NVMI Stock Ratings

Growth Rating 69.8
Fundamental 87.7
Dividend Rating 0.0
Rel. Strength 4.57
Analysts 4.43/5
Fair Price Momentum 176.50 USD
Fair Price DCF 98.84 USD

NVMI Dividends

No Dividends Paid

NVMI Growth Ratios

Growth Correlation 3m -85.2%
Growth Correlation 12m 5.2%
Growth Correlation 5y 83.9%
CAGR 5y 36.73%
CAGR/Max DD 5y 0.70
Sharpe Ratio 12m 0.45
Alpha -5.45
Beta 1.803
Volatility 75.92%
Current Volume 296.3k
Average Volume 20d 278.3k
What is the price of NVMI stocks?
As of April 19, 2025, the stock is trading at USD 175.62 with a total of 296,290 shares traded.
Over the past week, the price has changed by -2.31%, over one month by -11.41%, over three months by -32.06% and over the past year by +3.31%.
Is Nova a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Nova (NASDAQ:NVMI) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 87.68 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NVMI as of April 2025 is 176.50. This means that NVMI is currently overvalued and has a potential downside of 0.5%.
Is NVMI a buy, sell or hold?
Nova has received a consensus analysts rating of 4.43. Therefor, it is recommend to buy NVMI.
  • Strong Buy: 5
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for NVMI stock price target?
According to ValueRays Forecast Model, NVMI Nova will be worth about 201.3 in April 2026. The stock is currently trading at 175.62. This means that the stock has a potential upside of +14.62%.
Issuer Forecast Upside
Wallstreet Target Price 283 61.2%
Analysts Target Price 236 34.4%
ValueRay Target Price 201.3 14.6%